Androgenetic alopecia with Norwood-Hamilton stage II-IV oxyresveratrol, androgenic alopecia, hair tonic
Conditions
Interventions
Hair tonic formulated with 1% oxyresveratrol, 1,3Butylene glycol PEG-40 hydrogenated castor oil, EDTA, and water,2,4-Diamino-6-piperidinopyrimidine 3-oxide,- Hair tonic formulated with 1% oxyresveratr
Active Comparator Other,Placebo Comparator Other,Active Comparator Other
1% ORV hair tonic,3% minoxidil hair tonic,1% ORV hair tonic + 3% minoxidil hair tonic
Sponsors
Ratchadapisek Research Fund - Type 2
Eligibility
Sex/Gender
Male
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Androgenetic alopecia with Norwood-Hamilton stage II-IV
Exclusion criteria
Exclusion criteria: 1. Systemic Skin Diseases 2. Other Skin Rashes in the study area 3. Allergy to ORV or hair tonic components 4. Use of topical immunosuppressants, corticosteroids, minoxidil, or finasteride within 4 weeks 5. Light/Laser treatment within 4 weeks 6. Use of oral immunosuppressants, corticosteroids (>20 mg/day), minoxidil, finasteride, or dutasteride within 18 weeks 7. Live vaccines or immunotherapy within 4 weeks 8. Presence of cancer or autoimmune diseases 9. History of hair transplantation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair count Baseline, week 8, week 16, week 24 by fotofinder (total hair count, terminal hair counts, vellus hair counts) | — |
Secondary
| Measure | Time frame |
|---|---|
| Hair diameter Baseline, week 8, week 16, week 24 by fotofinder ,Satisfaction score week 24 score from 0 to 10 | — |
Countries
Thailand
Contacts
Public ContactJongkonnee Wongpiyabovorn
Faculty of Medicine, Chulalongkorn University
Outcome results
None listed